These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30317972)

  • 1. Nanoparticles in Daily Life: Applications, Toxicity and Regulations.
    Gupta R; Xie H
    J Environ Pathol Toxicol Oncol; 2018; 37(3):209-230. PubMed ID: 30317972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physio-pathological impacts of inhaled nanoparticles].
    Baeza-Squiban A
    Biol Aujourdhui; 2014; 208(2):151-8. PubMed ID: 25190574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.
    Bakand S; Hayes A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles: their potential toxicity, waste and environmental management.
    Bystrzejewska-Piotrowska G; Golimowski J; Urban PL
    Waste Manag; 2009 Sep; 29(9):2587-95. PubMed ID: 19427190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health impact and toxicological effects of nanomaterials in the lung.
    Kendall M; Holgate S
    Respirology; 2012 Jul; 17(5):743-58. PubMed ID: 22449246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.
    Umair M; Javed I; Rehman M; Madni A; Javeed A; Ghafoor A; Ashraf M
    J Pharm Pharm Sci; 2016; 19(2):161-80. PubMed ID: 27518167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology of nanoparticles.
    Elsaesser A; Howard CV
    Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches for safer design of engineered nanomaterials.
    Hwang R; Mirshafiee V; Zhu Y; Xia T
    Ecotoxicol Environ Saf; 2018 Dec; 166():294-300. PubMed ID: 30273853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity.
    Rivera-Gil P; Jimenez de Aberasturi D; Wulf V; Pelaz B; del Pino P; Zhao Y; de la Fuente JM; Ruiz de Larramendi I; Rojo T; Liang XJ; Parak WJ
    Acc Chem Res; 2013 Mar; 46(3):743-9. PubMed ID: 22786674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Cellular Toxicology of Nanomaterials with Related to Aquatic Organisms.
    Rather MA; Bhat IA; Sharma N; Sharma R
    Adv Exp Med Biol; 2018; 1048():263-284. PubMed ID: 29453544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Control Banding be Useful for the Safe Handling of Nanomaterials? A Systematic Review.
    Eastlake A; Zumwalde R; Geraci C
    J Nanopart Res; 2016; 18():. PubMed ID: 27471426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical hazard evaluation strategy for nanomedicines.
    Siegrist S; Cörek E; Detampel P; Sandström J; Wick P; Huwyler J
    Nanotoxicology; 2019 Feb; 13(1):73-99. PubMed ID: 30182784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles toxicity and their routes of exposures.
    Yah CS; Simate GS; Iyuke SE
    Pak J Pharm Sci; 2012 Apr; 25(2):477-91. PubMed ID: 22459480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking initial environmental and human health risk resulting from environmentally relevant nanomaterials.
    O'Brien N; Cummins E
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2010; 45(8):992-1007. PubMed ID: 20486008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate and risks of nanomaterials in aquatic and terrestrial environments.
    Batley GE; Kirby JK; McLaughlin MJ
    Acc Chem Res; 2013 Mar; 46(3):854-62. PubMed ID: 22759090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.